IL17A and breast cancer: Reinforcing such observation, qRT-PCR analysis of TILs expanded from 4 breast cancer patients’ biopsies showed that all the 4 samples were negative or limit to detection (TIL AL) for IL-17B mRNA expression, while half of them expressed IL-17A mRNA (Supplementary Figure 2).